In conclusion, the evidence to date does not support an increased risk of polyposis and/or CRC for carriers of monoallelic NTHL1 LoF variants, and consequently, no additional surveillance is currently warranted beyond population screening for CRC, unless family history characteristics point to a reason for colonoscopy. This evidence concerns the gene NTHL1 and colorectal carcinoma.